'Avatar' Sequel Now Ranks Fourth All-Time In Global Sales


(MENAFN- The Peninsula) AFP

Los Angeles: 'Avatar: The Way of Water' continued to dominate the box-office charts, taking in an estimated $15.7 million this weekend in North American theaters to make it the fourth-leading global grosser of all time.

The Disney/20thCentury sci-fi film, directed by James Cameron, 'has been #1 for 7 straight weeks... a feat that hasn't been accomplished' since Cameron issued the original 'Avatar' in 2009, industry watcher Exhibitor Relations said on Twitter.

Hefty results from theaters around the world -- including $237 million in ticket sales in China -- helped boost 'The Way of Water' to fourth place globally all-time at $2.117 billion, unadjusted for inflation.

That means Cameron now has his name on three of the four top grossers ever: the original 'Avatar', 'Titanic' and 'The Way of Water' ('Avengers: Endgame' from Disney and Marvel sneaks in at second).

In second place for the North American weekend was Universal's family-friendly 'Puss in Boots: The Last Wish', at $10.6 million for the Friday-through-Sunday period.

In third, up two spots from last weekend, was Sony's feel-good 'A Man Called Otto' at $6.8 million. Tom Hanks plays the title curmudgeon in the adaptation of Swedish novel 'A Man Called Ove'.

Scary-doll thriller 'M3GAN' from Universal and Blumhouse Productions took in $6.4 million to place fourth. It has an android doll, created as a companion to a young orphan, turning steadily creepier.

And Yash Raj Films' new action thriller 'Pathaan' placed fifth at $5.9 million, an impressive North American total for a Hindi-language film. It stars Shah Rukh Khan, known as the 'King of Bollywood', in a story about spies, rogue agents and a deadly lab-generated virus.

Rounding out the top 10 were:

'Missing' ($5.7 million)
'Plane' ($3.9 million)
'Infinity Pool' ($2.7 million)
'Left Behind: Rise of the Antichrist' ($2.3 million)
'The Wandering Earth 2' ($1.4 million)

MENAFN29012023000063011010ID1105492538


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.